MTD
Mettler-Toledo International Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +2.3% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 53.78K | $81.23M | n/a | −1 |
| Q2 2026 | 160 | +3 | 14.90M | $19.03B | +6 | −4 |
| Q1 2026 | 161 | 0 | 14.22M | $18.04B | +7 | −8 |
| Q4 2025 | 160 | 0 | 15.72M | $21.91B | +2 | −1 |
| Q3 2025 | 19 | +2 | 8.06M | $9.89B | +2 | −1 |
| Q2 2025 | 15 | -4 | 7.17M | $8.42B | n/a | −4 |
| Q1 2025 | 16 | 0 | 2.78M | $3.28B | n/a | n/a |
| Q4 2024 | 16 | -1 | 2.66M | $3.25B | n/a | −1 |
| Q3 2024 | 16 | 0 | 1.76M | $2.64B | n/a | n/a |
| Q2 2024 | 16 | n/a | 1.72M | $2.40B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 547.44K | +0.8% | $818.91M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | T. Rowe Price ✦ | 429.87K | +23.5% | $644.67M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 294.96K | +3.6% | $442.35M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 177.96K | +17.4% | $266.89M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 5 | Baillie Gifford ✦ | 97.00K | -46.4% | $145.48M | 0.1% | ▼ Trim | 2 | SEC ↗ ×4 |
| 6 | Marshall Wace ✦ | 80.24K | -4.8% | $120.34M | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Adage Capital Partners ✦ | 48.96K | +696.0% | $73.42M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 29.19K | +67.7% | $42.96M | 0.1% | ▲ Add | 2 | SEC ↗ ×4 |
| 9 | Two Sigma Investments ✦ | 15.59K | -41.6% | $23.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 9.60K | -24.6% | $14.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 8.73K | -50.2% | $13.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 6.88K | +212.3% | $10.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 6.05K | -84.0% | $9.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 4.50K | +80.4% | $6.75M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 3.27K | -9.9% | $4.90M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | Citadel Advisors ✦ | 109 | -90.6% | $163,467 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 815 holders, 19.62M shares, $23.18B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 942 sh · $1.34M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology